Dave Mesko Brings Experience in Nonprofits, Finance, Strategy, Management and Process
DENVER – The International Association for the Study of Lung Cancer (IASLC) welcomes Dave Mesko as its new Managing Director. Mr. Mesko comes to the IASLC with a strong background in running organizations and in creating new initiatives. Mr. Mesko will have primary responsibility for the overall operation of the organization. He reports to the CEO and has eight direct reports.
“Mr. Mesko has exactly the background and the leadership capabilities we need to move the IASLC to the next level,” said Fred R. Hirsch, MD, PhD, CEO of the IASLC. “We have grown significantly as an organization, both in people and in activities, and Mr. Mesko will help us manage that growth and plan strategically for the future.”
Over the past five years, the IASLC has grown from a staff of five to a staff of 23, and an average of three to five scientific meetings per year to 10 meetings in 2018.
In his most recent position prior to joining the IASLC, Mr. Mesko was Chief Operating Officer at the Council on Foundations. He was recruited as CFO as part of a comprehensive turnaround and reorganization, including a new five-year strategic plan, new executive team, new systems and new business processes. He was promoted within two years to add COO responsibilities (also encompassing the CFO role).
Mr. Mesko also served as CFO at Georgetown University, School of Nursing and Health Studies. While there he partnered with the executive team to evaluate business models, academic offerings and pricing. At Georgetown, Mr. Mesko led the paradigm shift required to move a traditional academic institution to the online education space.
In all of his previous positions, Mr. Mesko has exceeded financial targets, led innovative initiatives and developed effective processes. He has an MBA from the American University and a B.A. in Business Administration from Western Carolina University.
About International Association for the Study of Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information and follow us on Twitter @IASLC.